Author

Micah S. Simmons

University of Alabama at Birmingham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2

Frequent Co-Authors

James H. Meador‐WoodruffiD· 2 shared Vahram H. HaroutunianiD· 2 shared Ashley T. Helix· 1 shared Chang-Gyu Hahn· 1 shared Erica A. K. DePasqualeiD· 1 shared James K. ReigleiD· 1 shared Jarek MelleriD· 1 shared Khaled AlganemiD· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

James H. Meador‐WoodruffORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity

Xiaojun Wu, Rammohan Shukla, Khaled Alganem, Erica A. K. DePasquale, James K. Reigle, Micah S. Simmons, Chang-Gyu Hahn, Vahram H. Haroutunian, Jarek Meller, James H. Meador‐Woodruff, Robert Erne McCullumsmith

The paper identifies lamina-specific gene expression changes in pyramidal neurons from schizophrenia patients compared to controls, highlighting immune and synaptic pathway disruptions.

Biological Psychiatry · May 1, 2020Peer-reviewedNeuroscience

Glycosylation enzyme mRNA expression in dorsolateral prefrontal cortex of elderly patients with schizophrenia: Evidence for dysregulation of multiple glycosylation pathways

Toni Mueller, Micah S. Simmons, Ashley T. Helix, Vahram H. Haroutunian, James H. Meador‐Woodruff

The paper identifies dysregulated mRNA expression of 36 glycosylation enzymes in schizophrenia patients, suggesting disrupted glycosylation pathways contribute to the disorder.

bioRxiv · Jul 14, 2018 · PreprintNeuroscience